VacciNEWS – Page 11 – Global Health Press

Latest Science Outbreak Countries

ViVa news roundup — Week of 11–18 May 2026

Over roughly the past week to 18 May 2026, the main actionable developments have been a new WHO COVID‑19 antigen recommendation, regional RSV and influenza program moves (especially in Australia and Latin America), and...

20 May, 2026

7 min read

GHP News Latest Science

The May 2026 Hantavirus outbreak on a cruise ship

WHO reports a multi‑country cluster of Andes hantavirus linked to a Dutch‑flagged cruise ship. As of 8 May 2026, eight cases (six confirmed, two probable) and three deaths (case fatality ratio 38%) have been detected...

13 May, 2026

4 min read

GHP News Latest Science

Literature update ViVa week 19-2026

1. Australia’s child flu vaccine slide is the real post-COVID warning This multicenter prospective test-negative surveillance study enrolled 8,762 influenza-positive hospitalizations and 10,955 influenza-negative...

13 May, 2026

20 min read

GHP News Latest Science

Vaccines and Vaccination (ViVa) 19 news

Asia (SE Asia, China, India) No new schedule or policy updates from CDC-equivalents this week. We found no fresh national immunization schedule changes or formal vaccine-policy statements from CDC-equivalent agencies in...

13 May, 2026

6 min read

Latest Science

Licensing – relevant principles

Licensing (or licensure) of a vaccine means that a national regulatory authority has formally reviewed all the data on a vaccine based on predefined criteria and characteristics and granted permission for it to be...

7 May, 2026

5 min read

GHP News Latest Science

A possible step forward in prevention of rabies

Despite efforts to reduce canine transmission, rabies still claims in the region of 60,000 human lives each year, mainly in lower and middle-income countries. (1) Effective vaccines exist and may be used for pre...

7 May, 2026

2 min read

GHP News Latest Science

Literature update ViVa week 18-2026

1. MenB vaccines show lab cross-protection against MenX—but conjugates are still the gold standard In this laboratory study, investigators evaluated whether the protein-based meningococcal B vaccines 4CMenB (Bexsero)...

7 May, 2026

13 min read

GHP News Latest Science

Vaccines and Vaccination (ViVa) 18 news

Over the last week, developments have centered on immunization weeks and campaign intensification, selective adult RSV and influenza policy refinements, and several notable regulatory and manufacturing moves for...

7 May, 2026

10 min read

All Articles